Background Outcomes of diabetes care are unequal and the NHS has a duty to consider reducing inequality in healthcare outcomes. Aim To quantify trends in socioeconomic inequality and diabetes outcomes. Design and setting Whole-population longitudinal study of 32 482 neighbourhoods (Lower Layer Super Output Areas [LSOAs]) in England between 2004/2005 and 2011/2012. Method Slope indices of inequality (SIIs) between neighbourhoods of great and little deprivation were measured annually for: glycated haemoglobin control in people with diabetes; emergency hospitalisation for diabetes; and amenable mortality from diabetes. Results From 2004/2005 to 2011/2012 glycaemic control improved in all social groups, regardless of deprivation level, although...
THE IMPACT OF QOF ON INEQUALITIES IN THE PROCESS AND OUTCOME OF DIABETES CARE: A SYSTEMATIC REVIEWAu...
The major increase in the prevalence of diabetes mellitus (DM) has led to the study of social inequa...
AIMS: To assess any disparities in the initiation of second-line antidiabetic treatments prescribed ...
Background Outcomes of diabetes care are unequal and the NHS has a duty to consider reducing inequal...
Background Outcomes of diabetes care are unequal and the NHS has a duty to consider reducing inequal...
Background: Outcomes of diabetes care are unequal and the NHS has a duty to consider reducing inequa...
Objective This study aimed to determine changes in absolute and relative socio-economic inequalities...
Introduction Previous analyses suggest that over the first 3 years of the national Quality and Outco...
P05 Exploring the impact of the quality and outcomes framework on the quality of diabetes care and h...
To investigate the effect of social deprivation and ethnicity on inpatient admissions due to diabete...
Introduction Quality of care could be influenced by individual socio-economic status (SES) and by re...
The NHS Diabetes Prevention Programme (DPP) in England is a behavioural intervention for preventing ...
Disparities in type 2 diabetes (T2D) care provision and clinical outcomes have been reported in the ...
OBJECTIVE: To evaluate socioeconomic disadvantage in prevalence, awareness and control of diabetes i...
Background: We report the first study to estimate the socioeconomic gap in period life expectancy (L...
THE IMPACT OF QOF ON INEQUALITIES IN THE PROCESS AND OUTCOME OF DIABETES CARE: A SYSTEMATIC REVIEWAu...
The major increase in the prevalence of diabetes mellitus (DM) has led to the study of social inequa...
AIMS: To assess any disparities in the initiation of second-line antidiabetic treatments prescribed ...
Background Outcomes of diabetes care are unequal and the NHS has a duty to consider reducing inequal...
Background Outcomes of diabetes care are unequal and the NHS has a duty to consider reducing inequal...
Background: Outcomes of diabetes care are unequal and the NHS has a duty to consider reducing inequa...
Objective This study aimed to determine changes in absolute and relative socio-economic inequalities...
Introduction Previous analyses suggest that over the first 3 years of the national Quality and Outco...
P05 Exploring the impact of the quality and outcomes framework on the quality of diabetes care and h...
To investigate the effect of social deprivation and ethnicity on inpatient admissions due to diabete...
Introduction Quality of care could be influenced by individual socio-economic status (SES) and by re...
The NHS Diabetes Prevention Programme (DPP) in England is a behavioural intervention for preventing ...
Disparities in type 2 diabetes (T2D) care provision and clinical outcomes have been reported in the ...
OBJECTIVE: To evaluate socioeconomic disadvantage in prevalence, awareness and control of diabetes i...
Background: We report the first study to estimate the socioeconomic gap in period life expectancy (L...
THE IMPACT OF QOF ON INEQUALITIES IN THE PROCESS AND OUTCOME OF DIABETES CARE: A SYSTEMATIC REVIEWAu...
The major increase in the prevalence of diabetes mellitus (DM) has led to the study of social inequa...
AIMS: To assess any disparities in the initiation of second-line antidiabetic treatments prescribed ...